- €152.16m
- €169.86m
- €192.09m
- 92
- 66
- 81
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 132 | 139 | 156 | 171 | 192 |
Cost of Revenue | |||||
Gross Profit | 115 | 122 | 132 | 140 | 155 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 122 | 125 | 141 | 158 | 178 |
Operating Profit | 9.65 | 14.1 | 14.7 | 12.7 | 13.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.11 | 13.5 | 14.6 | 12.1 | 12.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.09 | 10.6 | 11.8 | 9.57 | 9.87 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7.09 | 10.6 | 11.8 | 9.53 | 9.87 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.09 | 10.6 | 11.8 | 9.53 | 9.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.267 | 0.39 | 0.441 | 0.361 | 0.37 |
Dividends per Share |